Eli Lilly and Company has signed an agreement for the acquisition of biopharmace...
The recent reintroduction of the Pasteur Act seeks to address the global threat ...
UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC e...
The move follows a positive decision made by the EMA earlier this year, broadeni...
The companies will develop new molecules using Eleven's innovative DELiveri plat...
The US Federal Court overturned a previous ruling in the patent infringement cas...
The Centre for Advanced Imaging (CAI) of the University of Queensland in Austral...
Researchers turn to CRISPR to unlock one of the trickiest diseases to treat: Alz...
In the latest edition of STAT's Health Tech newsletter: Better Therapeutics race...
Causaly serves 12 of the top 20 pharmaceutical companies with technology that ai...
Yusimry is priced at $995 per carton of two autoinjectors compared to Humira’s p...
After a call to action on social media, J&J has allowed the generic production o...
CureVac adds one more patent to the growing tally in its counterclaim against Pf...
Theseus Pharmaceuticals has terminated its pan-variant tyrosine kinase receptor ...
Vistagen has received a Canadian Notice of Allowance for patent that is related ...
Gilead Sciences has entered into collaborations with CHAI and Penta ID network t...
